First Trust Direct Indexing’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,124
Closed -$612K 265
2024
Q3
$612K Sell
9,124
-3,897
-30% -$320K 0.03% 483
2024
Q2
$1.48M Buy
13,021
+530
+4% +$67K 0.09% 226
2024
Q1
$1.73M Buy
12,491
+2,571
+26% +$323K 0.13% 163
2023
Q4
$1.23M Buy
9,920
+1,418
+17% +$145K 0.11% 207
2023
Q3
$793K Sell
8,502
-887
-9% -$100K 0.09% 269
2023
Q2
$1.21M Buy
9,389
+196
+2% +$23.7K 0.13% 171
2023
Q1
$1.07M Sell
9,193
-374
-4% -$41.9K 0.13% 190
2022
Q4
$1.08M Sell
9,567
-180
-2% -$19.8K 0.14% 180
2022
Q3
$785K Buy
9,747
+883
+10% +$74.8K 0.11% 233
2022
Q2
$661K Buy
8,864
+860
+11% +$78.5K 0.09% 281
2022
Q1
$1.02M Buy
8,004
+344
+4% +$37.6K 0.12% 204
2021
Q4
$1.03M Sell
7,660
-104
-1% -$14.9K 0.13% 183
2021
Q3
$1.06M Sell
7,764
-1,432
-16% -$181K 0.15% 162
2021
Q2
$982K Buy
9,196
+2,856
+45% +$274K 0.15% 178
2021
Q1
$570K Buy
6,340
+252
+4% +$23.7K 0.15% 182
2020
Q4
$563K Buy
+6,088
New +$544K 0.15% 167

Other funds holding DXCM

First Trust Direct Indexing's DXCM Position: Q4 2024 in Review

First Trust Direct Indexing sold out of DexCom (DXCM) in Q4 2024, closing a stake of 9,124 shares — an estimated $612K sold.

First Trust Direct Indexing first reported a position in DXCM in Q4 2020 and held it in 16 quarters. The position peaked at $1.73M in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • First Trust Direct Indexing reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 9,124 DexCom shares in Q4 2024, an estimated $612K.
  • First Trust Direct Indexing first reported a position in DexCom in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's DexCom position peaked at $1.73M in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.